Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00773500 · ClinicalTrials.gov registry record
Impact of Vendor Systems on Ambulatory Medication Safety
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 20
- Enrollment target
NCT00773500: Completed study, sponsored by Weill Medical College of Cornell University.
NCT00773500 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00773500 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use.
Interventions
- OTHER Electronic prescribing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-10 |
What the finished NCT00773500 record still lists
NCT00773500 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Electronic prescribing is the first listed.
NCT00773500 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00773500 about?
NCT00773500 is a clinical study titled "Impact of Vendor Systems on Ambulatory Medication Safety". Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use...
What is the current status of trial NCT00773500?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-09. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00773500?
The interventions under investigation include: Electronic prescribing (OTHER).
Who is sponsoring clinical trial NCT00773500?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia